VMP 42088411000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Risedronate sodium 30mg tablets
BNF code 0606020R0AAABAB
Virtual Therapeutic Moiety Risedronate sodium
Date identifier became valid 21 Jul 2023
Previous product identifier 325984003
Basis of preferred name INNM - International Non-proprietary Name (Modified)
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Risedronate sodium
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Risedronate sodium 30mg tablets (A A H Pharmaceuticals Ltd)
Risedronate sodium 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Risedronate sodium 30mg tablets (Aspire Pharma Ltd)
Risedronate sodium 30mg tablets (Medihealth (Northern) Ltd)
Risedronate sodium 30mg tablets (Milpharm Ltd)
Risedronate sodium 30mg tablets (Phoenix Healthcare Distribution Ltd)
Risedronate sodium 30mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Risedronate sodium 30mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback